Sandrine Thuret-Hindges

Title: Sandrine Thuret-Hindges: Innovator in Alzheimer's Disease Diagnosis

Introduction

Sandrine Thuret-Hindges is a prominent inventor based in London, GB. She has made significant contributions to the field of neuroscience, particularly in the diagnosis of Alzheimer's disease. Her innovative work focuses on developing methods that can predict the progression of cognitive impairment in patients.

Latest Patents

Thuret-Hindges holds a patent for an assay designed for diagnosing Alzheimer's disease. The invention, titled "Assay for diagnosing Alzheimer's disease," provides an in vitro cell-based method for predicting the conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) in patients diagnosed with MCI. The method involves several steps, including culturing human hippocampal progenitor cells in serum obtained from the patient, determining cell proliferation levels, and monitoring apoptotic cell death. The outcomes of these steps are statistically analyzed to predict the likelihood of conversion from MCI to AD.

Career Highlights

Sandrine Thuret-Hindges is affiliated with King's College London, where she conducts her research and development work. Her dedication to advancing the understanding of Alzheimer's disease has positioned her as a key figure in the field.

Collaborations

Thuret-Hindges collaborates with notable colleagues, including Simon Lovestone and Jack Price, who contribute to her research efforts and enhance the impact of her work.

Conclusion

Sandrine Thuret-Hindges is a trailblazer in the realm of Alzheimer's disease diagnosis, with her innovative patent paving the way for improved patient outcomes. Her contributions to neuroscience continue to inspire advancements in medical research and diagnostics.